Description: Drug Repositioning : Bringing New Life to Shelved Assets and Existing Drugs, Hardcover by Barratt, Michael J. (EDT); Frail, Donald E. (EDT), ISBN 0470878274, ISBN-13 9780470878279, Brand New, Free P&P in the UK
The hows and whys of successful drug repositioning
Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout th demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy.
Drug Repositioning is divided into three parts:
-
Part 1, Drug Repositioning: Business Case, Strategies, and Operational Considerations, examines the medical and commercial drivers underpinning the quest to reposition existing drugs, guiding readers through the key strategic, technical, operational, and regulatory decisions needed for successful drug repositioning programs.
-
Part 2, Application of Technology Platforms to Uncover New Indications and Repurpose Existing Drugs, sets forth computational-based strategies, tools, and databases that have been designed for repositioning studies, screening approaches, including combinations of existing drugs, and a look at the development of chemically modified analogs of approved agents.
-
Part 3, Academic and Non-Profit Initiatives & the Role of Alliances in the Drug Repositioning Industry, explores current investigations for repositioning drugs to treat rare and neglected diseases, which are frequently overlooked by for-profit pharmaceutical companies due to their lack of commercial return.
Ths appendix provides valuable resources for drug repositioning researchers, including information on drug repositioning and reformulation companies, databases, government resources and organizations, regulatory agencies, and drug repositioning initiatives from academia and non-profits.
With this book as their guide, students and pharmaceutical researchers can learn how to use drug repositioning techniques to extend the lifespan and applications of existing drugs as well as maximize the return on investment in drug research and development.
Price: 94.28 GBP
Location: Castle Donington
End Time: 2024-11-28T00:23:44.000Z
Shipping Cost: 20.32 GBP
Product Images
Item Specifics
Return postage will be paid by: Buyer
Returns Accepted: Returns Accepted
After receiving the item, your buyer should cancel the purchase within: 30 days
Book Title: Drug Repositioning : Bringing New Life to Shelved Assets and Exis
Item Height: 241 mm
Item Width: 155 mm
Author: Donald E. Frail, Michael J. Barratt
Publication Name: Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs
Format: Hardcover
Language: English
Publisher: John Wiley & Sons INC International Concepts
Subject: Medicine
Publication Year: 2012
Type: Textbook
Item Weight: 884 g
Number of Pages: 498 Pages
